ELAN
Price
$12.51
Change
-$0.00 (-0.00%)
Updated
Oct 28 closing price
9 days until earnings call
PCRX
Price
$17.13
Change
-$0.00 (-0.00%)
Updated
Oct 28 closing price
2 days until earnings call
Ad is loading...

ELAN vs PCRX

Header iconELAN vs PCRX Comparison
Open Charts ELAN vs PCRXBanner chart's image
Elanco Animal Health
Price$12.51
Change-$0.00 (-0.00%)
Volume$3.05M
CapitalizationN/A
Pacira BioSciences
Price$17.13
Change-$0.00 (-0.00%)
Volume$387.71K
CapitalizationN/A
View a ticker or compare two or three
ELAN vs PCRX Comparison Chart
Loading...
ELAN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
PCRX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
ELAN vs. PCRX commentary
Oct 30, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ELAN is a Buy and PCRX is a StrongBuy.

COMPARISON
Comparison
Oct 30, 2024
Stock price -- (ELAN: $12.51 vs. PCRX: $17.13)
Brand notoriety: ELAN: Notable vs. PCRX: Not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: ELAN: 48% vs. PCRX: 44%
Market capitalization -- ELAN: $7.87B vs. PCRX: $1.36B
ELAN [@Pharmaceuticals: Other] is valued at $7.87B. PCRX’s [@Pharmaceuticals: Other] market capitalization is $1.36B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.41B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ELAN’s FA Score shows that 1 FA rating(s) are green whilePCRX’s FA Score has 0 green FA rating(s).

  • ELAN’s FA Score: 1 green, 4 red.
  • PCRX’s FA Score: 0 green, 5 red.
According to our system of comparison, ELAN is a better buy in the long-term than PCRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ELAN’s TA Score shows that 4 TA indicator(s) are bullish while PCRX’s TA Score has 4 bullish TA indicator(s).

  • ELAN’s TA Score: 4 bullish, 6 bearish.
  • PCRX’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, PCRX is a better buy in the short-term than ELAN.

Price Growth

ELAN (@Pharmaceuticals: Other) experienced а -0.87% price change this week, while PCRX (@Pharmaceuticals: Other) price change was -1.15% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +8.21%. For the same industry, the average monthly price growth was +10.22%, and the average quarterly price growth was -2.43%.

Reported Earning Dates

ELAN is expected to report earnings on Feb 19, 2025.

PCRX is expected to report earnings on Feb 27, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+8.21% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ELAN($7.87B) has a higher market cap than PCRX($1.36B). ELAN YTD gains are higher at: -16.040 vs. PCRX (-49.229). PCRX has higher annual earnings (EBITDA): 155M vs. ELAN (-224M). ELAN has more cash in the bank: 352M vs. PCRX (279M). PCRX has less debt than ELAN: PCRX (586M) vs ELAN (5.77B). ELAN has higher revenues than PCRX: ELAN (4.42B) vs PCRX (675M).
ELANPCRXELAN / PCRX
Capitalization7.87B1.36B581%
EBITDA-224M155M-145%
Gain YTD-16.040-49.22933%
P/E RatioN/A32.74-
Revenue4.42B675M654%
Total Cash352M279M126%
Total Debt5.77B586M985%
FUNDAMENTALS RATINGS
ELAN vs PCRX: Fundamental Ratings
ELAN
PCRX
OUTLOOK RATING
1..100
6080
VALUATION
overvalued / fair valued / undervalued
1..100
83
Overvalued
56
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9478
PRICE GROWTH RATING
1..100
5761
P/E GROWTH RATING
1..100
31100
SEASONALITY SCORE
1..100
3650

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PCRX's Valuation (56) in the Pharmaceuticals Other industry is in the same range as ELAN (83) in the Agricultural Commodities Or Milling industry. This means that PCRX’s stock grew similarly to ELAN’s over the last 12 months.

PCRX's Profit vs Risk Rating (100) in the Pharmaceuticals Other industry is in the same range as ELAN (100) in the Agricultural Commodities Or Milling industry. This means that PCRX’s stock grew similarly to ELAN’s over the last 12 months.

PCRX's SMR Rating (78) in the Pharmaceuticals Other industry is in the same range as ELAN (94) in the Agricultural Commodities Or Milling industry. This means that PCRX’s stock grew similarly to ELAN’s over the last 12 months.

ELAN's Price Growth Rating (57) in the Agricultural Commodities Or Milling industry is in the same range as PCRX (61) in the Pharmaceuticals Other industry. This means that ELAN’s stock grew similarly to PCRX’s over the last 12 months.

ELAN's P/E Growth Rating (31) in the Agricultural Commodities Or Milling industry is significantly better than the same rating for PCRX (100) in the Pharmaceuticals Other industry. This means that ELAN’s stock grew significantly faster than PCRX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ELANPCRX
RSI
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
83%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
63%
Bearish Trend 2 days ago
74%
Momentum
ODDS (%)
Bearish Trend 2 days ago
79%
N/A
MACD
ODDS (%)
Bearish Trend 2 days ago
67%
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
73%
Bearish Trend 2 days ago
78%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
73%
Bullish Trend 2 days ago
66%
Advances
ODDS (%)
Bullish Trend 2 days ago
65%
Bullish Trend 12 days ago
67%
Declines
ODDS (%)
Bearish Trend 6 days ago
72%
Bearish Trend 5 days ago
79%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
68%
Bearish Trend 2 days ago
73%
Aroon
ODDS (%)
Bearish Trend 2 days ago
77%
Bullish Trend 2 days ago
70%
View a ticker or compare two or three
Ad is loading...
ELAN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
PCRX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME22.732.16
+10.50%
GameStop Corp
BTC.X69907.7600001978.460900
+2.91%
Bitcoin cryptocurrency
AAPL233.401.99
+0.86%
Apple
SPY580.831.79
+0.31%
SPDR® S&P 500® ETF Trust
TSLA262.51-6.68
-2.48%
Tesla

ELAN and

Correlation & Price change

A.I.dvisor indicates that over the last year, ELAN has been loosely correlated with SNDL. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if ELAN jumps, then SNDL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ELAN
1D Price
Change %
ELAN100%
+0.81%
SNDL - ELAN
39%
Loosely correlated
+1.38%
TEVA - ELAN
33%
Loosely correlated
+2.63%
ACET - ELAN
33%
Poorly correlated
+2.14%
PCRX - ELAN
32%
Poorly correlated
+1.78%
TAK - ELAN
27%
Poorly correlated
+0.22%
More

PCRX and

Correlation & Price change

A.I.dvisor tells us that PCRX and ELAN have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PCRX and ELAN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PCRX
1D Price
Change %
PCRX100%
+1.78%
ELAN - PCRX
32%
Poorly correlated
+0.81%
TEVA - PCRX
28%
Poorly correlated
+2.63%
BMCS - PCRX
28%
Poorly correlated
N/A
ACET - PCRX
27%
Poorly correlated
+2.14%
SNDL - PCRX
26%
Poorly correlated
+1.38%
More